Form 8-K - Current report:
SEC Accession No. 0000914475-23-000043
Filing Date
2023-05-03
Accepted
2023-05-03 07:32:26
Documents
14
Period of Report
2023-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20230503.htm   iXBRL 8-K 30992
2 EX-99.1 q1-2023xearningsrelease.htm EX-99.1 172573
6 nbix-20230503_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-23-000043.txt   403418

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20230503.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20230503_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20230503_pre.xml EX-101.PRE 12512
8 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20230503_htm.xml XML 10380
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 23881691
SIC: 2836 Biological Products, (No Diagnostic Substances)